A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time
AGMB129-01-CL-109
Phase 1 other active
Quick answer
A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time for Fibrostenotic Crohn’s disease is a Phase 1 program (other) at Agomab Therapeutics NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Agomab Therapeutics NV
- Indication
- Fibrostenotic Crohn’s disease
- Phase
- Phase 1
- Modality
- other
- Status
- active